Global law firm Ashurst is advising Amalfi Bidco Limited (a newly formed company indirectly owned by Sheikh Holdings Group (Investments) Limited, Belgravia Investments Limited and Kensington Capital Limited, and funds managed by THCS IV GP S.à r.l. and TH Management IV S.à r.l. and advised by THCP Advisory Limited) in relation to its recommended cash and share acquisition of the entire issued and to be issued share capital of CareTech Holdings PLC (“CareTech”).
Pursuant to the terms of the offer, CareTech shareholders will receive 750 pence per share, valuing the issued and to be issued share capital of CareTech at approximately £870 million.
CareTech is a public limited company incorporated in England and Wales whose shares are admitted to the AIM-market of the London Stock Exchange. CareTech is one of the UK’s largest social care providers providing specialist care and services to children and adults, with a portfolio of 550 residential facilities and schools, across the UK.
The Ashurst team advising on this public to private and acting for Amalfi Bidco Limited is being led by partner and Global Chair Karen Davies, with fellow corporate partners David Carter and Braeden Donnelly and assisted by senior corporate associates Sara Hamzawi and Jade MacDonald, and associates Alexandra Brogan, Aaron Koh, Ariella Moses, Christine Chang. Senior associate Rebecca Servian assisted on the share incentives aspects. Finance partners Tim Rennie and Helen Burton also advised with assistance from senior associates Sarah Curry and Connor Lovie. Competition partner Nigel Parr, senior associate Christopher Eberhardt and associate Victoria Beswick advised on competition aspects. Tax partner Nicholas Gardener and associate Luis De Freitas assisted on tax aspects.